{"version":"1.0","type":"link","title":"ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors.","author_name":"van Aken ESM 외","author_url":"https://prs-insight.online/author/van%20Aken%20ESM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/90874","thumbnail_width":1200,"thumbnail_height":630}